Nuance Communications, Inc. (NASDAQ:NUAN): UBS said Nuance’s recent business trends are on track despite market noise. The firm said the healthcare business has returned to double-digit growth and that valuation is attractive. Shares are Buy rated with a $30 price target.
R.R. Donnelley & Sons Company (NASDAQ:RRD): Barclays said the sell-off in R.R. Donnelley related to the Moody’s debt downgrade is overdone. Shares are Overweight rated with a $16 price target.
Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.